Revenue
$112m
+9.8% ↑ vs $102m
A lower 22.2% tax rate flatters NPAT while EBITDA grew 5.1% versus 9.8% revenue, and operating cash conversion fell from 33.0% to 22.1%.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY25 vs HY24
Revenue
$112m
+9.8% ↑ vs $102m
EBITDA
$0.01m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net profit after tax
$0m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
$2.9m
-29.4% ↓ vs $4.1m
Operating profit
$0.01m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Profit before tax
$0m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Cash and cash equivalents
$0.07m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Total assets
$300.3m
+12.9% ↑ vs $266m
What changed
EBITDA grew only 5.1% to $13.0m, so EBITDA margin compressed as the company invested in sales and g2.0.
PBT rose 10.4% to $9.1m, broadly tracking revenue. NPAT, however, jumped 34.7% to $7.2m because the effective tax rate dropped to 22.2% from 35.5%; the 24.3-percentage-point gap between PBT and NPAT growth is almost entirely a tax-rate effect, not operating leverage.
Operating cash flow fell to $2.9m from $4.1m, cash conversion (OCF/EBITDA) dropped to 22.1% from 33.0%, and FCF pre-lease declined to $1.8m. The balance sheet remains debt-free with $70.7m in cash and NTA per share of $0.72.
What matters
The cleanest read on operating performance is PBT +10.4% against revenue +9.8% and EBITDA +5.1%. That implies modest underlying earnings progress with mild margin compression, not the step-change suggested by NPAT +34.7%. Investors should not extrapolate the headline growth rate without understanding whether 22.2% is a sustainable effective tax rate.
Cash conversion deteriorated materially. OCF/EBITDA at 22.1% versus 33.0% a year earlier means HY25 turned roughly two-thirds as much accounting profit into cash as HY24. Receivable days edged up to 45.6 from 44.2, and FCF/NPAT fell to 24.8% from 55.7%. This matters because reported earnings growth is no longer being matched by cash generation at the same rate.
Segment mix is rotating. Utilities revenue grew 7.2% to $92.8m but segment result fell to $8.3m from $9.9m, consistent with the disclosed 9% segment margin and management's commentary on increased sales and g2.0 investment. Veovo, smaller at $19.2m revenue, lifted segment result to $4.6m from $2.4m at a 24% margin. The dominant Utilities business is carrying the strategic spend while Veovo is supplying the incremental profit.
Expectations
Against HY25 EBITDA growth of 5.1% versus revenue of 9.8%, this implies a meaningful second-half acceleration in operating leverage that has not yet shown up in the interim numbers.
The shape context reinforces second-half reliance. In FY24, HY accounted for only 47.8% of full-year revenue, 52.2% of EBITDA, and notably just 11.8% of operating cash flow, so the cash result is the most second-half-weighted line historically. Annualising HY25 gives roughly $224m revenue, but the realised number depends on whether utilities project work and cash collection follow the FY24 shape.
Quality of result
PBT growth of 10.4% is consistent with revenue growth and looks operationally credible. NPAT growth of 34.7%, by contrast, is materially flattered by a lower effective tax rate, and durability of that rate is not established in the release.
Cash quality weakened. OCF of $2.9m sits well below PBT of $9.1m, FCF pre-lease of $1.8m covers only 24.8% of NPAT, and receivable days drifted higher. Capex remained light at roughly 1.0% of revenue, so the cash gap is not capex-driven; it is working-capital and timing-driven. With no debt and $70.7m of cash, the deterioration does not threaten solvency, but it does change how much weight to place on the headline NPAT number when assessing the underlying earnings power of the business.
Unresolved
This briefing cannot assess whether the lower effective tax rate, the cash-conversion shortfall, and the Utilities margin compression will normalise in the second half because no quantitative full-year guidance, hedging detail, or forward-work backlog disclosure was provided in the release.
Chat
Ask follow-up questions about Gentrack Group's HY25 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
1HFY25 Market Announcement
HY25 / results release1HFY25 Results Announcement
HY25 / results announcementHY25 Investor Presentation
HY25 / results presentationInterim Financial Statements March 2025
HY25 / financial reportFinancial Statements including Chair's Commentary
HY24 / financial reportMarket Announcement
HY24 / results releaseResults Announcement
HY24 / results announcementFY24 Financial Statements
FY24 / financial reportMarket Announcement
FY24 / results releaseResults Announcement
FY24 / results announcementHalf-Year Results Presentation Recording
HY25 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Cash conversion quality
This result converted 22.1% of EBITDA to operating cash flow, -10.8pp versus the prior comparable period.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 24.3pp, with a distortion flag in the result.
Dividend coverage and payout pressure
Dividend payout versus NPAT is 0.0%.
Leverage and balance-sheet risk
Net debt / EBITDA is -5.46x, -2.27x versus the prior comparable period.
Get the next Gentrack Group briefing and related NZX reporting-season updates by email.